Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

Overview

Journal Adv Mater

Date 2019 Jun 22

PMID 31222852

Citations 56

Authors

Hannah J Vaughan

Jordan J Green

Stephany Y Tzeng

Affiliations

Soon will be listed here.

Abstract

Nucleic acids are a promising type of therapeutic for the treatment of a wide range of conditions, including cancer, but they also pose many delivery challenges. For efficient and safe delivery to cancer cells, nucleic acids must generally be packaged into a vehicle, such as a nanoparticle, that will allow them to be taken up by the target cells and then released in the appropriate cellular compartment to function. As with other types of therapeutics, delivery vehicles for nucleic acids must also be designed to avoid unwanted side effects; thus, the ability of such carriers to target their cargo to cancer cells is crucial. Classes of nucleic acids, hurdles that must be overcome for effective intracellular delivery, types of nonviral nanomaterials used as delivery vehicles, and the different strategies that can be employed to target nucleic acid delivery specifically to tumor cells are discussed. Additonally, nanoparticle designs that facilitate multiplexed delivery of combinations of nucleic acids are reviewed.

Citing Articles

The Impact of Hyaluronic Acid Coating on the Cationic Niosomal Surface for Doxorubicin Delivery.

Mazzotta E, Romeo M, Sacco G, De Benedittis S, Qualtieri A, Perrotta I Molecules. 2025; 30(5).

PMID: 40076371 PMC: 11901725. DOI: 10.3390/molecules30051148.

TCL1A in naïve B cells as a therapeutic target for type 1 diabetes.

Luo S, Zhang L, Wei C, Guo C, Meng Z, Zeng H EBioMedicine. 2025; 113:105593.

PMID: 39946833 PMC: 11872515. DOI: 10.1016/j.ebiom.2025.105593.

Recent advances of self-assembled nanoparticles in the diagnosis and treatment of atherosclerosis.

Aili T, Zong J, Zhou Y, Liu Y, Yang X, Hu B Theranostics. 2024; 14(19):7505-7533.

PMID: 39659570 PMC: 11626940. DOI: 10.7150/thno.100388.

Nucleic acid drugs: recent progress and future perspectives.

Sun X, Setrerrahmane S, Li C, Hu J, Xu H Signal Transduct Target Ther. 2024; 9(1):316.

PMID: 39609384 PMC: 11604671. DOI: 10.1038/s41392-024-02035-4.

The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights.

Hao X, Ding M, Chi C, Xu X, Zhang X, Hu M Discov Oncol. 2024; 15(1):658.

PMID: 39546109 PMC: 11568081. DOI: 10.1007/s12672-024-01510-2.

References

Capan Y, Woo B, Gebrekidan S, Ahmed S, Deluca P . Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J Control Release. 1999; 60(2-3):279-86. DOI: 10.1016/s0168-3659(99)00076-0. View

Bies C, Lehr C, Woodley J . Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev. 2004; 56(4):425-35. DOI: 10.1016/j.addr.2003.10.030. View

Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W . Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. Adv Mater. 2016; 28(43):9581-9588. DOI: 10.1002/adma.201602173. View

Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S . Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Hum Gene Ther. 1999; 10(9):1509-19. DOI: 10.1089/10430349950017842. View

Yang S, Lin F, Tsai K, Wei M, Tsai H, Wong J . Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjug Chem. 2010; 21(4):679-89. DOI: 10.1021/bc9004798. View

Conde J, Oliva N, Zhang Y, Artzi N . Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater. 2016; 15(10):1128-38. PMC: 6594055. DOI: 10.1038/nmat4707. View

Putnam D . Polymers for gene delivery across length scales. Nat Mater. 2006; 5(6):439-51. DOI: 10.1038/nmat1645. View

Schulze J, Kuhn S, Hendrikx S, Schulz-Siegmund M, Polte T, Aigner A . Spray-Dried Nanoparticle-in-Microparticle Delivery Systems (NiMDS) for Gene Delivery, Comprising Polyethylenimine (PEI)-Based Nanoparticles in a Poly(Vinyl Alcohol) Matrix. Small. 2018; 14(12):e1701810. DOI: 10.1002/smll.201701810. View

Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Narayanannair Jayaprakash K . Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther. 2010; 18(7):1357-64. PMC: 2911264. DOI: 10.1038/mt.2010.85. View

10.

Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P . Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Acta Pharmacol Sin. 2012; 33(6):823-31. PMC: 4010380. DOI: 10.1038/aps.2012.34. View

11.

Li L, Dai H, Yeh F, Kan S, LANG J, Hsu J . Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy. Oncogene. 2010; 30(15):1773-83. DOI: 10.1038/onc.2010.558. View

12.

Stark G, Kerr I, Williams B, Silverman R, Schreiber R . How cells respond to interferons. Annu Rev Biochem. 1998; 67:227-64. DOI: 10.1146/annurev.biochem.67.1.227. View

13.

Meyer M, Philipp A, Oskuee R, Schmidt C, Wagner E . Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc. 2008; 130(11):3272-3. DOI: 10.1021/ja710344v. View

14.

Gaertner F, Kessler H, Wester H, Schwaiger M, Beer A . Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging. 2012; 39 Suppl 1:S126-38. DOI: 10.1007/s00259-011-2028-1. View

15.

Kuwabara P, Coulson A . RNAi--prospects for a general technique for determining gene function. Parasitol Today. 2000; 16(8):347-9. DOI: 10.1016/s0169-4758(00)01677-x. View

16.

Umeda M, Nojima S, Inoue K . Effect of lipid composition on HVJ-mediated fusion of glycophorin liposomes to erythrocytes. J Biochem. 1985; 97(5):1301-10. DOI: 10.1093/oxfordjournals.jbchem.a135181. View

17.

Katabi M, Chan H, Karp S, Batist G . Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Hum Gene Ther. 1999; 10(2):155-64. DOI: 10.1089/10430349950018959. View

18.

Hornick J, Xu J, Vangveravong S, Tu Z, Mitchem J, Spitzer D . The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine. Mol Cancer. 2010; 9:298. PMC: 3106998. DOI: 10.1186/1476-4598-9-298. View

19.

Jordan M, Schallhorn A, Wurm F . Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 1996; 24(4):596-601. PMC: 145683. DOI: 10.1093/nar/24.4.596. View

20.

Fan Z, Sun L, Huang Y, Wang Y, Zhang M . Bioinspired fluorescent dipeptide nanoparticles for targeted cancer cell imaging and real-time monitoring of drug release. Nat Nanotechnol. 2016; 11(4):388-94. DOI: 10.1038/nnano.2015.312. View